Impact of tetrabenazine on gait and functional mobility in individuals with Huntington's disease
Open Access
- 1 December 2014
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 347 (1-2) , 219-223
Abstract
No abstract availableKeywords
Funding Information
- Lundbeck LLC
- Robert A Vaughan Family Fund
This publication has 22 references indexed in Scilit:
- Clinical Assessment of the Effect of Tetrabenazine on Functional Scales in Huntington Disease: A Pilot Open Label StudyTremor and Other Hyperkinetic Movements, 2012
- Coordination of fingertip forces during precision grip in premanifest Huntington's diseaseMovement Disorders, 2011
- Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD InvestigatorsBMC Neurology, 2009
- Falls and gait disturbances in Huntington's diseaseMovement Disorders, 2008
- Reliability of spatiotemporal gait outcome measures in Huntington's diseaseMovement Disorders, 2005
- Zotepine in Huntington's diseaseHuman Psychopharmacology: Clinical and Experimental, 2003
- High-dose olanzapine in Huntington??s diseaseInternational Clinical Psychopharmacology, 2002
- Unified Huntington's disease rating scale: Reliability and consistencyMovement Disorders, 1996
- The gait abnormality of Huntington's diseaseNeurology, 1985
- Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1984